Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) offers a novel treatment option for patients with severe symptomatic aortic valve stenosis, particularly for patients who are unsuitable candidates for surgical intervention. However, high therapeutical costs, socio-economic considerations, and numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisler, Daniela, Rudziński, Piotr Nikodem, Hasan, Waseem, Andreas, Martin, Hasimbegovic, Ena, Adlbrecht, Christopher, Winkler, Bernhard, Weiss, Gabriel, Strouhal, Andreas, Delle-Karth, Georg, Grabenwöger, Martin, Mach, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584860/
https://www.ncbi.nlm.nih.gov/pubmed/34768430
http://dx.doi.org/10.3390/jcm10214911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584860/
https://www.ncbi.nlm.nih.gov/pubmed/34768430
http://dx.doi.org/10.3390/jcm10214911

Ejemplares similares